Stay updated on Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial
Sign up to get notified when there's something new on the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page.

Latest updates to the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.6.6 has been added to the study record, replacing the previous v3.6.5 to indicate an applied update. The change represents a metadata refresh and does not modify the study details, eligibility criteria, or user-facing functionality.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing Revision: v3.6.4. This indicates a minor version update to the page rather than any alteration to study data.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4, signaling a minor platform update. No study content or results appear to be affected.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, indicating a small page version update and no change to the study information or criteria.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a small maintenance update to the page rendering and metadata. No study data or content changes are indicated by this update.SummaryDifference0.1%

- Check93 days agoChange DetectedThe study page now indicates recruitment is closed to participants, and new help sections have been added (How to Read a Study Record, Common Questions, How to Join a Study) along with a formatting update to the Intervention/Treatment header and a revision/version change from v3.5.5 to v3.6.0.SummaryDifference0.7%

Stay in the know with updates to Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page.